Increasing drug testing throughput in neurological disorders
Embedded Files
MIAKER Bioassays has the capacity to carry out screening and testing molecules in in vitro and in vivo disease models, it has a platform suitable to perform toxicity and efficacy tests for clients involved in drug development.
MISSION
MISSION
Act as a driving agent for drugs in development for the treatment of neurodegenerative and neuromuscular diseases.
Act as a driving agent for drugs in development for the treatment of neurodegenerative and neuromuscular diseases.
VISION
VISION
Boost the transfer of medical technologies with the screening of new molecular entities with pharmacological interest.
Boost the transfer of medical technologies with the screening of new molecular entities with pharmacological interest.
VALUES
VALUES
Knowledge, Experience, Transparency, Integrity, and Constancy.
Page updated
Report abuse